Abstract
The concept that neoplasia results from an accumulation of somatic mutations in the tumour lineage is heuristically extremely useful. Strong support for this hypothesis has been provided by the demonstration that suitably altered proto-oncogenes can induce a neoplastic phenotype when introduced into normal recipient cells. However, activated oncogenes that behave in this phenotypically “dominant” fashion have been detected so far in only a minority of tumours and therefore the genetic basis of neoplasia in most cancers remains obscure. There are at least four explanations for the frequent failure to implicate positively acting oncogenes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anders F (1983) The biology of an oncogene, based upon studies in neoplasia in Xiphophorus. In: Neth R, Gallo R (eds) Modern trends in human leukemia 5. Springer, Berlin Heidelberg New York, p 186
Benedict WF, Weissman BE, Mark C, Stanbridge EG (1984) Tumorigenicity of human HT 1080 fibrosarcoma x normal fibroblast hybrids: chromosome dosage dependency. Cancer Res 44: 3471–3479
Chiswell DJ, Enrietto PJ, Evans S, Quade K, Wyke JA (1982a) Molecular mechanisms involved in morphological variation of avian sarcoma virus-infected rat cells. Virology 116: 428–440
Chiswell DJ, Gillespie DA, Wyke JA (1982b) The changes in proviral chromatin that accompany morphological variation in avian sarcoma virus-infected rat cells. Nucl Acids Res 10: 3967–3979
Comings DE (1973) A general theory of carcinogenesis. Proc Natl Acad Sci USA 70: 3324–3328
Craig RW, Sager R (1985) Suppression of tumorigenicity in hybrids of normal and oncogenetransformed CHEF cells. Proc Natl Acad Sci USA 82: 2062–2066
Dracopoli NC, Houghton AN, Old LJ (1985) Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogenicity. Proc Natl Acad Sci USA 82: 1470–1474
Dyson PJ, Quade K, Wyke JA (1982) Expression of the ASV src gene in hybrids between normal and virally transformed cells: specific suppression occurs in some hybrids but not others. Cell 30: 491–498
Dyson PJ, Cook PR, Searle S, Wyke JA (1985) The chromatin structure of Rous sarcoma proviruses is changed by factors that act in trans in cell hybrids. EMBO J 4: 413–420
Gateff E (1978) Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 200: 1448–1459
Green AR, Wyke JA (1985) Anti-oncogenes-a subset of regulatory genes involved in carcinogenesis? Lancet ii: 475–477
Griegel S, Traub O, Willecke K, Schafer R Suppression and reexpression of transformed phenotype in hybrids of Ha-ras 1 transformed Rat-1 cells and early passage rat embryo fibroblasts. Submitted
Guerrero I, Villasante A, Corces V, Pellicer A (1985) Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc Natl Acad Sci USA 82: 7810–7814
van Heyningen V, Boyd PA, Seawright A, Fletcher JM, Fantes JA, Buckton KE, Spowart G, Porteous DJ, Hill RE, Newton MS, Hastie ND (1985) Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome. Proc Natl Acad Sci USA 82: 8592–8596
Klinger HP (1982) Suppression of tumorigenicity. Cytogenet Cell Genet 32: 68–84
Klinger HP, Shows TB (1983) Suppression of tumorigenicity in somatic cell hybrids. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells. J Natl Cancer Inst 71: 559–569
Knudson AG (1985) Hereditary cancer, oncogenes, and anti-oncogenes. Cancer Res 45: 1437–1443
Marshall CJ, Dave H (1978) Suppression of the transformed phenotype in somatic cell hybrids. J Cell Sci 33: 171–190
Noda M, Selinger Z, Scolnick EM, Bassin RH (1983) Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci USA 80: 5602–5606
Sager R (1985) Genetic suppression of tumor formation. Adv Cancer Res 44: 43–68
Stanbridge EJ, Der CJ, Doersen C-J, Nishimi RY, Peehl DM, Weissman BE, Wilkinson JE (1982) Human cell hybrids: analysis of transformation and tumorigenicity. Science 215: 252–259
Wyke JA, Beamand JA, Varmus HE (1980) Factors affecting phenotypic reversion of rat cells transformed by avian sarcoma virus. Cold Spring Harbor Symp Quant Biol XLIV: 1065–1075
Yokota J, Tsunetsugu-Yokota Y, Battifora H, LeFevre C, Cline MJ (1986) Alterations of myc, myb, and ras Ha proto-oncogenes in cancers are frequent and show clinical correlation. Science 231: 261–265
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wyke, J.A., Green, A.R. (1986). Suppression of the Neoplastic Phenotype. In: Kahn, P., Graf, T. (eds) Oncogenes and Growth Control. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73325-3_47
Download citation
DOI: https://doi.org/10.1007/978-3-642-73325-3_47
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18760-8
Online ISBN: 978-3-642-73325-3
eBook Packages: Springer Book Archive